Melatonin treatment of shoulder-and-neck dyskinesia possibly related to fluoxetine treatment

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 3, 2009, Pages 1047-1048

  Bhakta, Savita G ^a   Andrade, Chittaranjan ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Dyskinesia; Fluoxetine; Melatonin; Risperidone

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; MELATONIN; RISPERIDONE; ANTIOXIDANT; SEROTONIN UPTAKE INHIBITOR;

ADULT; CASE REPORT; DRUG DOSE INCREASE; DYSKINESIA; FOLLOW UP; HUMAN; LETTER; MAJOR DEPRESSION; MALE; MOTOR DYSFUNCTION; NECK INJURY; OBSESSIVE COMPULSIVE DISORDER; SHOULDER DISEASE; NECK; PATHOPHYSIOLOGY; SHOULDER;

ANTIOXIDANTS; DYSKINESIA, DRUG-INDUCED; FLUOXETINE; HUMANS; MALE; MELATONIN; NECK; SEROTONIN UPTAKE INHIBITORS; SHOULDER; YOUNG ADULT;

EID: 77949525977     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970802650044     Document Type: Letter

References (10)

1. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, on behalf of the WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders. 2008. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders-first revision. World J Biol Psychiatry 9: 248-312.
2. Bharucha KJ, Sethi KD. 1996. Complex movement disorders induced by fluoxetine. Mov Disord 11:324-326.
3. Bilen S, Saka M, Ak F, Oztekin N. 2008. Persistent dystonia induced by fluoxetine. Intern Med J 38:672-674.
4. Dubovsky SL, Thomas. M. 1996. Tardive dyskinesia associated with fluoxetine. Psychiatr Serv 47:991-993.
5. Gerber PE, Lynd LD. 1998. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 32:692-698.
6. Leo RJ. 1996. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 57:449-454
7. Lohr JB, Kuczenski R, Niculescu AB. 2003. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17:47-62.
8. Naidu PS, Singh A, Kaur P, Sandhir R, Kulkarni SK. 2003. Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia. Pharmacol Biochem Behav 74:641-648. (Pubitemid 36126542)
9. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z. 2003. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 50:1129-1146.
10. Shamir E, Barak Y, Shalman I. 2001. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry 58:1049-1052.